Hello Anon,
Generally, comparative assessment physical/technology attributes and performance testing, as well as intended use and indications for should be all that is required for your equivalence argument in the submission.
You should not have to reverse engineer the predicate product for biocompatibility. Your own biocomp testing should be sufficient, provided it is performed in a qualified lab, and testing endpoints are selected/justified based on your biocompatibility risk assessment (related to your device's material composition, manufacturing processes, and intended use).
FDA does not typically accept the argument that your device is composed of exactly the same materials as the predicate and therefore you don't have to test your device for biocompatibility. This is because you don't know where your competitor obtained their materials and how they processed it to get to the final device.
Note, if you using your own device as predicate for a modified device, you might be able to claim that if nothing changed, but be prepared to justify it in the biocomp section of the submission.
Good luck. I suggest you look at competitive 510k summaries in your product code (FDA database) for examples of how others position their SE statements.
------------------------------
Ginger Cantor, MBA, RAC
Founder/Principal Consultant
Centaur Consulting LLC
River Falls, Wisconsin 54022 USA
715-307-1850
centaurconsultingllc@gmail.com------------------------------
Original Message:
Sent: 04-Jul-2023 11:10
From: Anonymous Member
Subject: Substantial Equivalence - Technological Characteristics
This message was posted by a user wishing to remain anonymous
For 510(k) substantial equivalence to predicate and specifically the technological characteristics from a material perspective, is it sufficient to demonstrate physical equivalence or is it necessary to also demonstrate material composition equivalence? <o:p></o:p>For example, if the new device is a tube that is implanted into a patient and but there is limited information available on the predicate 510(k) in relation to the material composition, is it sufficient to provide the dimensional characteristic comparison (length, OD, ID, tensile, etc.) to the predicate device or do you need to perform material testing (FTIR, etc), to determine the material content of the predicate in addition to biocompatibility, etc.? Is it acceptable to perform this type of reverse engineering for a 510(k) Substantial Equivalence?<o:p></o:p>